Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer. [electronic resource]
Producer: 20190408Description: 130-138.e2 p. digitalISSN:- 1938-0690
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- therapeutic use
- Deoxycytidine -- analogs & derivatives
- ErbB Receptors -- immunology
- Female
- Humans
- Immunotherapy -- methods
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Survival Analysis
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.